Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Chiara FanciulliJuan BerenguerCarmen BuscaMaría J VivancosMaría J TéllezLourdes DomínguezPere DomingoJordi NavarroJesús SantosJosé A IribarrenLuis MoranoArturo ArteroJavier MorenoAntonio Rivero-RománIgnacio SantosLivia GinerCarlos ArmiñanzasMarta MonteroChristian ManzardoCarmen CifuentesCoral GarcíaMaría J GalindoOscar L FerreroJosé SanzBelén de la FuenteCarmen RodríguezGabriel GasparLaura PérezJuan E LosaLuis ForceSergio VelosoElisa Martínez-AlfaroInmaculada JarrínMarta De MiguelJuan González Garcianull nullPublished in: HIV medicine (2022)
In Spain, the prevalence of active HCV infection among PLWH at the end of 2019 was 2.2%, i.e. 90.0% lower than in 2015. Increased exposure to DAAs was probably the main reason for this sharp reduction. Despite the high coverage of treatment with direct-acting antiviral agents, HCV-related cirrhosis remains significant in this population.